In this study, we aimed to investigate the niacin-I148M polymorphism crosstalk in NAFLD patients and examine niacin’s beneficial effect in reducing fat by exploiting hepatoma cells with different PNPLA3 genotype. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.